Clinical characteristics and prognosis of non-small cell lung cancer patients with liver metastasis: A population-based study

Figure 1 Incidence and survival of non-small cell lung cancer-liver metastasis. A: The age-adjusted incidence of non-small cell lung cancer patients with liver metastasis between 2010 and 2018; B: Kaplan-Meier curves showing cancer-specific survival of patients with liver, bone, and brain metastasis.

Figure 2 Nomogram for predicting 3-, 6-, and 12-mo cancer-specific survival of patients presenting with liver metastases at the initial diagnosis of non-small cell lung cancer.

Figure 3 Calibration curves for predictions of cancer-specific survival at 3, 6, and 12 mo. A: Training cohort; B: Validation cohort. CSS: Cancer-specific survival.

Figure 4 Decision curves of the nomogram for predicting cancer-specific survival at 3 mo, 6 mo, and 12 mo in the training cohort. A: 3 mo; B: 6 mo; C: 12 mo.

Figure 5 Kaplan–Meier curves of cancer-specific survival for patients in the training cohort according to the novel risk stratification. Low risk vs intermediate risk, P < 0.001; low risk vs high risk, P < 0.001; intermediate risk vs high risk, P < 0.001.